Variant report
Variant | nsv528276 |
---|---|
Chromosome Location | chr2:141354396-141362222 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1372256 | chr2:141354396-141354397 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs1441469 | chr2:141354420-141354421 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs368319253 | chr2:141354446-141354447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs142047619 | chr2:141354461-141354462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563520263 | chr2:141354506-141354507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs3793149 | chr2:141354507-141354508 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs568332358 | chr2:141354540-141354541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs61539815 | chr2:141354593-141354594 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs185541533 | chr2:141354596-141354597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs3793148 | chr2:141354604-141354605 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs114040567 | chr2:141354607-141354608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs115744181 | chr2:141354617-141354618 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190135689 | chr2:141354623-141354624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557220337 | chr2:141354634-141354635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570608202 | chr2:141354644-141354645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs114888378 | chr2:141354679-141354680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559029498 | chr2:141354686-141354687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs557415522 | chr2:141354700-141354701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146287933 | chr2:141354701-141354702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541071114 | chr2:141354702-141354703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs488610 | chr2:141354744-141354745 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs537205450 | chr2:141354752-141354753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs116181599 | chr2:141354823-141354824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs543693354 | chr2:141354837-141354838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs568256247 | chr2:141354850-141354851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563796453 | chr2:141354897-141354898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532764313 | chr2:141354904-141354905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs558910248 | chr2:141354908-141354909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs78966513 | chr2:141354939-141354940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs375785445 | chr2:141354956-141354957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181756802 | chr2:141354958-141354959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs528164475 | chr2:141354993-141354994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs36050170 | chr2:141354994-141354995 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs474837 | chr2:141354997-141354998 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs371516809 | chr2:141355011-141355012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs75191769 | chr2:141355027-141355028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs372635625 | chr2:141355033-141355034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs550907245 | chr2:141355046-141355047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs570624743 | chr2:141355054-141355055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552729300 | chr2:141355081-141355082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539621041 | chr2:141355084-141355085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs492190 | chr2:141355107-141355108 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs139562346 | chr2:141355149-141355150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs534774533 | chr2:141355218-141355219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554580451 | chr2:141355252-141355253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs115237943 | chr2:141355324-141355325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs144494894 | chr2:141355334-141355335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs494227 | chr2:141355375-141355376 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs577426310 | chr2:141355381-141355382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs373659353 | chr2:141355383-141355384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma | 21080181 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Autism | 22543975 | CNVD |
Cancer | 20164920 | CNVD |
Hypertension | 22686481 | CNVD |
Hypospadia | 22686481 | CNVD |
Intellectual disability | 22686481 | CNVD |
Omphalocele | 22686481 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Prostate cancer | 22341455 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:141351800-141359000 | Weak transcription | Pancreas | Pancrea |
2 | chr2:141353800-141354400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr2:141354200-141357800 | Weak transcription | A549 | lung |
4 | chr2:141355400-141355800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr2:141357400-141358200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr2:141357400-141358200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr2:141357600-141358200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr2:141357600-141358200 | Enhancers | NH-A | brain |
9 | chr2:141357600-141358400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr2:141357800-141358200 | Enhancers | A549 | lung |
11 | chr2:141358200-141361400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
12 | chr2:141358200-141362000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr2:141358400-141361000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr2:141359000-141359200 | ZNF genes & repeats | Pancreas | Pancrea |
15 | chr2:141361000-141362200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr2:141361400-141363000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr2:141362000-141362200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
18 | chr2:141362200-141362600 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
19 | chr2:141362200-141362800 | Enhancers | GM12878-XiMat | blood |